The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation.

Nasdaq 100 futures were up 0.6% while S&P 500 futures gained 0.5% and Dow futures 0.4%. Europe’s Stoxx 600 Index also advanced, with auto and consumer stocks outperforming.